Mycobacterium tuberculosis strains of the Beijing lineage are globally distributed and are
associated with the massive spread of multidrug-resistant (MDR) tuberculosis in Eurasia. Here …

Extrapulmonary tuberculosis (EPTB) accounts for more than 20% of tuberculosis (TB) cases.
Xpert MTB/RIF (Xpert) (Cepheid, Sunnyvale, CA, USA) is a fully automated amplification …

Background Molecular diagnostics are considered the most promising route to achievement
of rapid, universal drug susceptibility testing for Mycobacterium tuberculosis complex (MTBC…

Identifying latently infected individuals is crucial for the elimination of tuberculosis (TB). We
evaluated for the first time the performance of a new type of interferon-γ release assay, …

Background The risk of tuberculosis outbreaks among people fleeing hardship for refuge in
Europe is heightened. We describe the cross-border European response to an outbreak of …

Resistance to fluoroquinolones (FLQ) and second-line injectable drugs (SLID) is steadily
increasing, especially in eastern European countries, posing a serious threat to effective …

Tuberculosis elimination requires an effective strategy to diagnose and treat people infected
with Mycobacterium tuberculosis who would otherwise be at high risk of developing and …

Background The clinical application of IFN-γ release assays (IGRAs) has recently improved
the diagnosis of latent tuberculosis infection. In a multicenter study of the Tuberculosis …

Objectives To develop a robust phenotypic antimicrobial susceptibility testing (AST) method
with a correctly set breakpoint for pretomanid (Pa), the most recently approved anti-…

Low-level rifampin resistance associated with specific rpoB mutations (referred as “disputed”)
in Mycobacterium tuberculosis is easily missed by some phenotypic methods. To …